Company profile: Lifecore Biomedical
1.1 - Company Overview
Company description
- Provider of hyaluronan-based products and parenteral CDMO services, including U.S.-produced, non-animal-sourced sodium hyaluronate for research, clinical, and commercial use in various molecular weights; Corgel BioHydrogel biocompatible, customizable hydrogels; and specialty formulation, aseptic filling, final packaging, process development, clinical and commercial manufacturing, and cGMP analytical and ICH-compliant stability services.
Products and services
- Parenteral CDMO Services: Engineers specialty formulation, conducts aseptic filling, and manages final packaging of complex injectable medical devices and pharmaceutical drug products, employing aseptic handling throughout
- Premium Sodium Hyaluronate: Produces non-animal-sourced, U.S.-manufactured sodium hyaluronate for research, clinical, and commercial applications, offered in various molecular weights
- Analytical & Stability Services: Operates on-site laboratories for sample control and timeline management, delivering full cGMP quality control analysis and ICH-compliant stability studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lifecore Biomedical
Minakem
HQ: France
Website
- Description: Provider of pharmaceutical intermediates and active pharmaceutical ingredients for life sciences industries, offering API manufacturing for innovative and generic drugs, including highly potent APIs; custom development and manufacturing; production of key intermediates; comprehensive analytical services from substance development to marketing authorization; and corticosteroid API manufacturing at a Montreal facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Minakem company profile →
Knipper Health
HQ: United States
Website
- Description: Provider of life sciences 3PL warehousing and distribution (including cold-chain management, DEA storage, and serialization compliance); an independent specialty pharmacy; integrated pharmaceutical sample management and distribution; prescriber matching and validation; and patient assistance, adherence, and advocacy through a contact center.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Knipper Health company profile →
Apicore
HQ: United States
Website
- Description: Provider of process R&D and active pharmaceutical ingredient (API) manufacturing services for the pharmaceutical industry worldwide, specializing in difficult-to-synthesize, high-value, and niche specialty APIs, serving customers in the generic medicine industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apicore company profile →
Ardena
HQ: Belgium
Website
- Description: Provider of pharmaceutical development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ardena company profile →
Noramco
HQ: United States
Website
- Description: Provider of design, construction, and management services for bulk active pharmaceutical ingredient plants, including a Wilmington, Delaware facility supporting Ortho-McNeil Pharmaceutical's Tylenol with codeine business; expanded through the acquisition of Tasmanian Alkaloids and the addition of an Athens, Georgia site in 1982.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noramco company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lifecore Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lifecore Biomedical
2.2 - Growth funds investing in similar companies to Lifecore Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lifecore Biomedical
4.2 - Public trading comparable groups for Lifecore Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →